Actively Recruiting
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients
Led by Santa Chiara Hospital · Updated on 2024-06-25
3000
Participants Needed
3
Research Sites
624 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this observational study is to evaluate the clinical outcomes of treatment with docetaxel, ARTA (alone or in combination) or with radiotherapy on the primary tumor for mCSPC, in an unselected population, in clinical practice
CONDITIONS
Official Title
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed diagnosis of adenocarcinoma of the prostate with metastatic disease, not previously treated except hormone therapy started no more than 4 to 6 months before docetaxel
- Treatment with docetaxel, androgen receptor pathway inhibitors alone or in combination, or radiotherapy on the primary tumor combined with androgen deprivation therapy started between January 2015 and December 2027
- Availability of inpatient and/or outpatient medical records for clinical data collection
You will not qualify if you...
- Histological diagnosis other than adenocarcinoma
- Previous multiple lines of androgen deprivation therapy for metastatic hormone-sensitive prostate cancer
- Previous treatment with docetaxel or androgen receptor targeting agents for metastatic castration-resistant prostate cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Azienda Ospedaliera San Luigi
Orbassano, Torino, Italy, 10043
Actively Recruiting
2
Istituto Oncologico Veneto
Padova, Italy, 35128
Actively Recruiting
3
Santa Chiara Hospital
Trento, Italy, 38122
Actively Recruiting
Research Team
O
Orazio Caffo, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here